1.
Dementia in Parkinson's disease: a 20-year neuropsychological study (Sydney Multicentre Study)
by Reid, W G J
Journal of neurology, neurosurgery and psychiatry, 2011, Vol.82 (9), p.1033-1037
2.
Individualized High-Dose Cabergoline Therapy for Hyperprolactinemic Infertility in Women with Micro- and Macroprolactinomas
by Ono, Masami
The journal of clinical endocrinology and metabolism, 2010, Vol.95 (6), p.2672-2679
3.
Prolactin, autoimmunity, and motherhood: when should women avoid breastfeeding?
by Vieira Borba, Vânia
Clinical rheumatology, 2019, Vol.38 (5), p.1263-1270
4.
Transient psychosis in women on clomiphene, bromocriptine, domperidone and related endocrine drugs
by Seeman, Mary V.
Gynecological endocrinology, 2015, Vol.31 (10), p.751-754
5.
Parathyroid Hormone-Related Protein-Induced Hypercalcemia of Pregnancy Successfully Reversed by a Dopamine Agonist
by Winter, Elizabeth M
The journal of clinical endocrinology and metabolism, 2017, Vol.102 (12), p.4417-4420
6.
Infertility, Treatment of Infertility, and the Risk of Breast Cancer among Women with BRCA1 and BRCA2 Mutations: A Case-Control Study
by Kotsopoulos, Joanne
Cancer causes & control, 2008, Vol.19 (10), p.1111-1119
7.
Cabergoline in the treatment of hyperprolactinemia : A study in 455 patients
by VERHELST, J
The journal of clinical endocrinology and metabolism, 1999, Vol.84 (7), p.2518-2522
8.
Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: Prevalence, clinical definition, and therapeutic strategy
by DI SARNO, Antonella
The journal of clinical endocrinology and metabolism, 2001, Vol.86 (11), p.5256-5261
9.
The Effect of Atorvastatin on Cardiometabolic Risk Factors in Bromocriptine‐Treated Premenopausal Women with Isolated Hypercholesterolemia
by Krysiak, Robert
Cardiovascular therapeutics, 2015, Vol.33 (5), p.282-287
10.
Peripartum cardiomyopathy, place of drug therapy, assist devices, and outcome after left ventricular assistance
by Hamdan, Righab, M.D
Journal of critical care, 2016, Vol.37, p.185-188
11.
Sleep attacks and Parkinson's disease treatment
by Ferreira, JJ
The Lancet (British edition), 2000, Vol.355 (9212), p.1333-1334
12.
Hyperprolactinemia in children: clinical features and long-term results
by Catli, Gonul
Journal of Pediatric Endocrinology and Metabolism, 2012, Vol.25 (11-12), p.1123-1128
13.
Dopamine agonists in prevention of ovarian hyperstimulation syndrome
by Kasum, Miro
Gynecological endocrinology, 2014, Vol.30 (12), p.845-849
14.
Prolactin: a new therapeutic target in peripartum cardiomyopathy
by Yamac, Hatice
Heart, 2010, Vol.96 (17), p.1352-1357
15.
Contrasting effects of bromocriptine on learning of a partially baited radial arm maze task in the presence and absence of restraint stress
by SRIKUMAR, B. N
Psychopharmacologia, 2007, Vol.193 (3), p.363-374
16.
The effects of bromocriptine on VEGF, kidney function and ovarian hyperstimulation syndrome in in vitro fertilization patients: a pilot study
by Beltrame, Ana Lúcia
Gynecological endocrinology, 2013, Vol.29 (3), p.201-204
17.
Laboratory and Clinical Experience in 55 Patients with Macroprolactinemia Identified by a Simple Polyethylene Glycol Precipitation Method
by Leslie, H
The journal of clinical endocrinology and metabolism, 2001, Vol.86 (6), p.2743-2746
18.
Attenuation of working memory and spatial acquisition deficits after a delayed and chronic bromocriptine treatment regimen in rats subjected to traumatic brain injury by controlled...
by KLINE, Anthony E
Journal of neurotrauma, 2002, Vol.19 (4), p.415-425
19.
Bromocriptine-induced Brainstem Angulation in a Patient With Invasive Prolactinoma
by Lou, Xiao Hui
The journal of clinical endocrinology and metabolism, 2013, Vol.98 (3), p.867-868
20.
Delayed ischemic stroke associated with bromocriptine-induced reversible cerebral vasoconstriction syndrome
by Kim, Young Seo
Neurological sciences, 2012, Vol.34 (3), p.409-411
